C. Difficile

>

Latest News

VE303's Phase 3 Trial Targets Clostridioides difficile Recurrence
VE303's Phase 3 Trial Targets Clostridioides difficile Recurrence

March 14th 2024

Successful phase 2 trial leads to phase 3 trial towards managing C difficile.

Top 5 Infectious Disease Stories Week of March 2
Top 5 Infectious Disease Stories Week of March 2

March 8th 2024

Assessing the Efficacy and Risks of Oral Vancomycin Prophylaxis for Clostridioides difficile Infections
Assessing the Efficacy and Risks of Oral Vancomycin Prophylaxis for Clostridioides difficile Infections

March 4th 2024

Fecal Microbiota-Based Therapies Approach to Treat Clostridioides Difficile
Fecal Microbiota-Based Therapies Approach to Treat Clostridioides Difficile

February 26th 2024

Top Infectious Disease Stories: Week of February 10
Top Infectious Disease Stories: Week of February 10

February 16th 2024

Video Series
Video Interviews
Podcasts

More News

© 2024 MJH Life Sciences

All rights reserved.